Company
Switch Therapeutics
Switch Therapeutics is developing biomarker-gated, innovative genetic medicines to transform the treatment of central nervous system diseases.
Also known as SWITCH THERAPEUTICS INC.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- South San Francisco, CA, United States
- Founded
- 2020
- Legal name
- SWITCH THERAPEUTICS INC.
- switchthera.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We are an emerging precision neuroscience biotechnology company pioneering a new type of RNAi medicine with the goal of treating a range of CNS diseases.
Funding snapshot
- Total raised
- $23.3MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $23.3M2022-09-27
Funding rounds
- Round, 2022
- $23.3M2022-09-27, SEC form D sold, 15 investors
Loading relationship preview